title: [Dermatitis herpetiformis. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
authors.affiliation: Service de dermatologie, hôpital Henri-Mondor, 51 avenue Maréchal-de-Lattre-de-Tassigny, Créteil, France. saskia.oro@hmn.aphp.fr
authors.forename: S
authors.initials: S
authors.lastname: Ingen-Housz-Oro
authors.forename: P
authors.initials: P
authors.lastname: Joly
authors.forename: P
authors.initials: P
authors.lastname: Bernard
authors.forename: C
authors.initials: C
authors.lastname: Bedane
authors.forename: C
authors.initials: C
authors.lastname: Prost
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001706:Biopsy; D002446:Celiac Disease / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000178:diet therapy; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000175:diagnosis* / Q000178:diet therapy / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000473:pathology; D055050:Diet, Gluten-Free; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010348:Patient Care Team; D010353:Patient Education as Topic; D012698:Serologic Tests
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003622:Dapsone